The role of electrochemotherapy in the treatment of locally advanced or recurrent eyelid‐periocular basal cell carcinoma: long‐term results
International Journal of Dermatology · 2025
DOI: 10.1111/ijd.17346 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Attila Vass und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Electrochemotherapy, Bleomycin, Eyelid Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
While electrochemotherapy (ECT) is increasingly utilized as a highly effective method in the treatment of tumors in the head and neck region, there is significantly less data available for eyelid‐periocular skin tumors. Our group reported the first extensive case series of eyelid‐periocular basal cell carcinoma (BCC) patients with short‐term follow‐up treatment with ECT. The present study aims to report our long‐term results of eyelid‐periocular BCC cases treated with ECT.
Methods
The treatments were performed according to the ESOPE (European Standard Operating Procedures on Electrochemotherapy) guidelines using the Cliniporator™ device. All patients received bleomycin‐based ECT, administered intratumorally or intravenously. Tumor response was evaluated using the RECIST 1.1 criteria.
Results
The results of 19 patients treated with ECT are presented. Four patients had locally advanced primary tumors, while 15 patients had recurrent tumors. Bleomycin was administered intratumorally in four patients and intravenously in 15 patients. The overall response was 100%, while the complete response rate proved to be 95%. In three cases (15.8%), recurrence was observed during the mean follow‐up period of 78.9 months.
Conclusions
ECT can effectively treat locally advanced or recurrent BCC in the eyelid‐periocular skin region. Excellent tumor control can be achieved with good functional and cosmetic results without systemic adverse events with long interval follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Szeged, Szeged, Hungary.
- Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
- Department of Oncotherapy, University of Szeged, Szeged, Hungary.
- Faculty of Health Sciences and Social Studies, University of Szeged, Szeged, Hungary.
ORCID-Profile: Petra Rózsa, Edit Tóth-Molnár
Zitieren
APA
Vass, A., Polgár, N., Sándor, S. A., Ágoston, D., Rózsa, P., Csányi, I., Ócsai, H., Baltás, E., Oláh, J., Kis, E. G., & Tóth-Molnár, E. (2025). The role of electrochemotherapy in the treatment of locally advanced or recurrent eyelid‐periocular basal cell carcinoma: long‐term results. International Journal of Dermatology. https://doi.org/10.1111/ijd.17346
Vancouver
Vass A, Polgár N, Sándor SA, Ágoston D, Rózsa P, Csányi I, et al. The role of electrochemotherapy in the treatment of locally advanced or recurrent eyelid‐periocular basal cell carcinoma: long‐term results. International Journal of Dermatology. 2025. doi:10.1111/ijd.17346
BibTeX
@article{Vass2025,
author = {Vass, Attila and Polgár, Nóra and Sándor, Szilvia Alexa and Ágoston, Dóra and Rózsa, Petra and Csányi, Ildikó and Ócsai, Henriette and Baltás, Eszter and Oláh, Judit and Kis, Erika Gabriella and Tóth-Molnár, Edit},
title = {The role of electrochemotherapy in the treatment of locally advanced or recurrent eyelid‐periocular basal cell carcinoma: long‐term results},
journal = {International Journal of Dermatology},
year = {2025},
doi = {10.1111/ijd.17346}
}
EUVIMED